What is Texas Senate Bill 3?
As it stands, current Texas law permits hemp-derived products with less than 0.3% THC content, which are widely available at more than 8,000 locations throughout the state. In comparison to a...more
7/3/2025
/ Agribusiness ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Compassionate Use Act ,
Enforcement ,
Farm Bill ,
Food and Drug Administration (FDA) ,
Government Agencies ,
Governor Abbott ,
Governor Vetoes ,
Hemp ,
Intoxication ,
Marijuana ,
New Legislation ,
Plant Based Products ,
Product Labels ,
Proposed Legislation ,
Regulatory Reform ,
State Legislatures ,
Tax Revenues ,
Texas ,
THC
The much-anticipated hearings on the proposed rulemaking to reschedule cannabis, which were scheduled to begin on January 21, have been postponed for at least three months as a result of an appeal granted by DEA...more
2/5/2025
/ Administrative Law Judge (ALJ) ,
Agribusiness ,
Appeals ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Marijuana ,
Medical Marijuana ,
Plant Based Products ,
Rulemaking Process ,
Schedule I Drugs ,
Trump Administration
On September 23, 2024, California Governor Gavin Newsom announced emergency regulations that, among other things, prohibited hemp products containing any “detectable” amount of THC. The next day, September 24, several small...more
As the cannabis rescheduling process progresses and we enter the fourth quarter of 2024, many cannabis businesses are wondering what’s next and how rescheduling may impact 280E and tax planning.
In this session, Vicente...more
After 50 years of being on the most restrictive schedule alongside drugs like heroin and PCP, the DEA will move to reschedule marijuana in Schedule III, where the plant’s medical benefits will finally be recognized by the...more
5/1/2024
/ Agribusiness ,
Controlled Substances Act ,
Corporate Counsel ,
DEA ,
Decriminalization of Marijuana ,
Department of Justice (DOJ) ,
Financial Services Industry ,
Food and Drug Administration (FDA) ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Medical Research ,
Popular ,
Schedule I Drugs